- Home
- BIOA vs OPRX Comparison
BIOA vs OPRX Comparison
Compare BIOA & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIOA
- OPRX
- Stock Information
- Founded
- BIOA 2015
- OPRX 2006
- Country
- BIOA United States
- OPRX United States
- Employees
- BIOA N/A
- OPRX N/A
- Industry
- BIOA Biotechnology: Pharmaceutical Preparations
- OPRX Business Services
- Sector
- BIOA Health Care
- OPRX Consumer Discretionary
- Exchange
- BIOA Nasdaq
- OPRX Nasdaq
- Market Cap
- BIOA 144.1M
- OPRX 154.9M
- IPO Year
- BIOA 2024
- OPRX N/A
- Fundamental
- Price
- BIOA $4.11
- OPRX $9.91
- Analyst Decision
- BIOA Hold
- OPRX Buy
- Analyst Count
- BIOA 4
- OPRX 8
- Target Price
- BIOA $5.67
- OPRX $9.06
- AVG Volume (30 Days)
- BIOA 246.5K
- OPRX 155.8K
- Earning Date
- BIOA 05-06-2025
- OPRX 05-12-2025
- Dividend Yield
- BIOA N/A
- OPRX N/A
- EPS Growth
- BIOA N/A
- OPRX N/A
- EPS
- BIOA N/A
- OPRX N/A
- Revenue
- BIOA $1,451,000.00
- OPRX $92,127,000.00
- Revenue This Year
- BIOA N/A
- OPRX $12.12
- Revenue Next Year
- BIOA N/A
- OPRX $10.87
- P/E Ratio
- BIOA N/A
- OPRX N/A
- Revenue Growth
- BIOA N/A
- OPRX 28.81
- 52 Week Low
- BIOA $2.88
- OPRX $3.78
- 52 Week High
- BIOA $26.62
- OPRX $14.13
- Technical
- Relative Strength Index (RSI)
- BIOA N/A
- OPRX 66.01
- Support Level
- BIOA N/A
- OPRX $9.12
- Resistance Level
- BIOA N/A
- OPRX $10.38
- Average True Range (ATR)
- BIOA 0.00
- OPRX 0.65
- MACD
- BIOA 0.00
- OPRX 0.06
- Stochastic Oscillator
- BIOA 0.00
- OPRX 78.79
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.